Market Cap 370.80M
Revenue (ttm) 40,000.00
Net Income (ttm) -88.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -220,225.00%
Debt to Equity Ratio 0.15
Volume 14,733,700
Avg Vol 3,925,564
Day's Range N/A - N/A
Shares Out 130.11M
Stochastic %K 6%
Beta 0.34
Analysts Strong Sell
Price Target $18.00

Company Profile

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Industry: Biotechnology
Sector: Healthcare
Phone: 240 654 1450
Address:
910 Clopper Road, Suite 201S, Gaithersburg, United States
Babybock
Babybock Apr. 27 at 10:32 AM
$ALT grabbing a few this morning to start my week off on the right foot.
0 · Reply
saad545
saad545 Apr. 27 at 10:31 AM
$ALT we will stay here until you cover and lose your money⬆️🔥
0 · Reply
GreenEnergy2022
GreenEnergy2022 Apr. 27 at 10:05 AM
$ALT Stocks goes up and down, 2,8 is not the end of the story here. Now we buy, and then we wait. Simplest thing in life
0 · Reply
lottomillions
lottomillions Apr. 27 at 10:05 AM
$ALT @Turribull You have by your own admission had a 5-7B target on this for the 16th of April. Only off by a breathtakingly bad 1000%. Those naive enough to listen to you have lost enough. Have a little bit of reflection on the damage you did to those peoples portfolios with the relentless promotion campaign.
0 · Reply
OutlawBikerRR
OutlawBikerRR Apr. 27 at 9:52 AM
$ALT ARE WE HAPPY FOR 2.88$ ??
0 · Reply
Babybock
Babybock Apr. 27 at 9:29 AM
0 · Reply
AF5
AF5 Apr. 27 at 9:04 AM
0 · Reply
PrecisionGuidanceNetwork
PrecisionGuidanceNetwork Apr. 27 at 8:48 AM
$ALT biotech with sharp catalyst-driven volatility around major updates
0 · Reply
DragonAlgo
DragonAlgo Apr. 27 at 8:44 AM
🐉 $ALT PUT — DragonAlgo® Signal Contract: ALT PUT Expiry: 2026-05-01 | Strike: $3.00 | Type: PUT Option Plan (premium): Entry: $0.20 Stop: $0.14 TP1: $0.26 TP2: $0.34 TP3: $0.48 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
Rich1979
Rich1979 Apr. 27 at 7:41 AM
0 · Reply
Latest News on ALT
Altimmune Transcript: AGM 2026

Apr 16, 2026, 8:30 AM EDT - 10 days ago

Altimmune Transcript: AGM 2026


Altimmune Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 9:20 AM EDT - 6 weeks ago

Altimmune Transcript: Leerink Global Healthcare Conference 2026


Altimmune Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 7 weeks ago

Altimmune Earnings Call Transcript: Q4 2025


Altimmune to Participate in Upcoming Investor Conferences

Mar 2, 2026, 7:30 AM EST - 7 weeks ago

Altimmune to Participate in Upcoming Investor Conferences


Altimmune (ALT) Shares Slide On $75 Million Stock Offering

Jan 28, 2026, 4:13 PM EST - 3 months ago

Altimmune (ALT) Shares Slide On $75 Million Stock Offering


Altimmune Transcript: Study Result

Dec 19, 2025, 8:00 AM EST - 4 months ago

Altimmune Transcript: Study Result


Altimmune Announces CEO Transition and Succession Plan

Dec 1, 2025, 7:30 AM EST - 5 months ago

Altimmune Announces CEO Transition and Succession Plan


Altimmune Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 10:00 AM EST - 5 months ago

Altimmune Transcript: Stifel 2025 Healthcare Conference


Altimmune Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 6 months ago

Altimmune Earnings Call Transcript: Q3 2025


Altimmune to Participate in Two Upcoming Investor Conferences

Nov 5, 2025, 7:30 AM EST - 6 months ago

Altimmune to Participate in Two Upcoming Investor Conferences


Altimmune Transcript: Stifel Virtual Cardiometabolic Forum

Sep 30, 2025, 10:30 AM EDT - 7 months ago

Altimmune Transcript: Stifel Virtual Cardiometabolic Forum


Altimmune Transcript: AGM 2025

Sep 25, 2025, 8:30 AM EDT - 7 months ago

Altimmune Transcript: AGM 2025


Altimmune Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 9 months ago

Altimmune Earnings Call Transcript: Q2 2025


Altimmune Transcript: Study Result

Jun 26, 2025, 8:30 AM EDT - 10 months ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Altimmune Earnings Call Transcript: Q1 2025


Altimmune Transcript: R&D Day 2025

Mar 13, 2025, 12:00 PM EDT - 1 year ago

Altimmune Transcript: R&D Day 2025


Altimmune Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Altimmune Earnings Call Transcript: Q4 2024


Altimmune Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 9:30 AM EST - 1 year ago

Altimmune Transcript: Guggenheim SMID Cap Biotech Conference


Altimmune Transcript: UBS Global Healthcare Conference 2024

Nov 13, 2024, 12:30 PM EST - 1 year ago

Altimmune Transcript: UBS Global Healthcare Conference 2024


Altimmune Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Altimmune Earnings Call Transcript: Q3 2024


Altimmune Transcript: 8th Annual MASH Investor Conference

Oct 7, 2024, 11:30 AM EDT - 1 year ago

Altimmune Transcript: 8th Annual MASH Investor Conference


Altimmune Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Altimmune Earnings Call Transcript: Q2 2024


Altimmune Transcript: UBS Obesity Therapeutics Day

May 23, 2024, 10:00 AM EDT - 2 years ago

Altimmune Transcript: UBS Obesity Therapeutics Day


Altimmune Transcript: The Citizens JMP Life Sciences Conference

May 14, 2024, 9:00 AM EDT - 2 years ago

Altimmune Transcript: The Citizens JMP Life Sciences Conference


Altimmune Earnings Call Transcript: Q1 2024

May 9, 2024, 8:30 AM EDT - 2 years ago

Altimmune Earnings Call Transcript: Q1 2024


Altimmune Earnings Call Transcript: Q4 2023

Mar 27, 2024, 8:30 AM EDT - 2 years ago

Altimmune Earnings Call Transcript: Q4 2023


Altimmune Transcript: Study Result

Dec 1, 2023, 8:30 AM EST - 2 years ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:30 AM EST - 2 years ago

Altimmune Earnings Call Transcript: Q3 2023


Altimmune Earnings Call Transcript: Q2 2023

Aug 10, 2023, 8:30 AM EDT - 2 years ago

Altimmune Earnings Call Transcript: Q2 2023


Altimmune Earnings Call Transcript: Q1 2023

May 11, 2023, 8:30 AM EDT - 3 years ago

Altimmune Earnings Call Transcript: Q1 2023


Altimmune Transcript: Study Result

Mar 21, 2023, 9:00 AM EDT - 3 years ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q4 2022

Feb 28, 2023, 8:30 AM EST - 3 years ago

Altimmune Earnings Call Transcript: Q4 2022


Altimmune Transcript: Study Result

Dec 20, 2022, 8:00 AM EST - 3 years ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q3 2022

Nov 10, 2022, 11:00 AM EST - 3 years ago

Altimmune Earnings Call Transcript: Q3 2022


Altimmune Transcript: Study Result

Sep 14, 2022, 8:30 AM EDT - 3 years ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q2 2022

Aug 11, 2022, 8:15 AM EDT - 4 years ago

Altimmune Earnings Call Transcript: Q2 2022


Altimmune Earnings Call Transcript: Q1 2022

May 12, 2022, 2:30 PM EDT - 4 years ago

Altimmune Earnings Call Transcript: Q1 2022


Altimmune Earnings Call Transcript: Q4 2021

Mar 15, 2022, 9:47 AM EDT - 4 years ago

Altimmune Earnings Call Transcript: Q4 2021


Altimmune Earnings Call Transcript: Q3 2021

Nov 8, 2021, 7:00 PM EST - 4 years ago

Altimmune Earnings Call Transcript: Q3 2021


Altimmune Transcript: KOL Event

Sep 30, 2021, 9:00 AM EDT - 4 years ago

Altimmune Transcript: KOL Event


Altimmune Transcript: Study Result

Sep 28, 2021, 8:30 AM EDT - 4 years ago

Altimmune Transcript: Study Result


Altimmune Earnings Call Transcript: Q2 2021

Aug 11, 2021, 6:02 AM EDT - 5 years ago

Altimmune Earnings Call Transcript: Q2 2021


Altimmune Transcript: Study Update

Jun 16, 2021, 8:30 AM EDT - 5 years ago

Altimmune Transcript: Study Update


Altimmune Earnings Call Transcript: Q1 2021

May 17, 2021, 9:37 AM EDT - 5 years ago

Altimmune Earnings Call Transcript: Q1 2021


Altimmune Earnings Call Transcript: Q4 2020

Feb 25, 2021, 8:30 AM EST - 5 years ago

Altimmune Earnings Call Transcript: Q4 2020


Altimmune Earnings Call Transcript: Q3 2020

Nov 10, 2020, 8:30 AM EST - 5 years ago

Altimmune Earnings Call Transcript: Q3 2020


Altimmune Transcript: AGM 2020

Sep 24, 2020, 10:00 AM EDT - 6 years ago

Altimmune Transcript: AGM 2020


Altimmune Earnings Call Transcript: Q2 2020

Aug 12, 2020, 8:30 AM EDT - 6 years ago

Altimmune Earnings Call Transcript: Q2 2020


Altimmune Transcript: Status Update

Jun 1, 2020, 8:30 AM EDT - 6 years ago

Altimmune Transcript: Status Update


Altimmune Earnings Call Transcript: Q1 2020

May 14, 2020, 8:30 AM EDT - 6 years ago

Altimmune Earnings Call Transcript: Q1 2020


Babybock
Babybock Apr. 27 at 10:32 AM
$ALT grabbing a few this morning to start my week off on the right foot.
0 · Reply
saad545
saad545 Apr. 27 at 10:31 AM
$ALT we will stay here until you cover and lose your money⬆️🔥
0 · Reply
GreenEnergy2022
GreenEnergy2022 Apr. 27 at 10:05 AM
$ALT Stocks goes up and down, 2,8 is not the end of the story here. Now we buy, and then we wait. Simplest thing in life
0 · Reply
lottomillions
lottomillions Apr. 27 at 10:05 AM
$ALT @Turribull You have by your own admission had a 5-7B target on this for the 16th of April. Only off by a breathtakingly bad 1000%. Those naive enough to listen to you have lost enough. Have a little bit of reflection on the damage you did to those peoples portfolios with the relentless promotion campaign.
0 · Reply
OutlawBikerRR
OutlawBikerRR Apr. 27 at 9:52 AM
$ALT ARE WE HAPPY FOR 2.88$ ??
0 · Reply
Babybock
Babybock Apr. 27 at 9:29 AM
0 · Reply
AF5
AF5 Apr. 27 at 9:04 AM
0 · Reply
PrecisionGuidanceNetwork
PrecisionGuidanceNetwork Apr. 27 at 8:48 AM
$ALT biotech with sharp catalyst-driven volatility around major updates
0 · Reply
DragonAlgo
DragonAlgo Apr. 27 at 8:44 AM
🐉 $ALT PUT — DragonAlgo® Signal Contract: ALT PUT Expiry: 2026-05-01 | Strike: $3.00 | Type: PUT Option Plan (premium): Entry: $0.20 Stop: $0.14 TP1: $0.26 TP2: $0.34 TP3: $0.48 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
Rich1979
Rich1979 Apr. 27 at 7:41 AM
0 · Reply
Lynxtail
Lynxtail Apr. 27 at 6:56 AM
0 · Reply
GreenEnergy2022
GreenEnergy2022 Apr. 27 at 6:48 AM
0 · Reply
thaines1
thaines1 Apr. 27 at 6:35 AM
1 · Reply
Corpkcots
Corpkcots Apr. 27 at 6:32 AM
0 · Reply
DerStorch
DerStorch Apr. 27 at 6:18 AM
0 · Reply
MakeAmericaSlimAgain
MakeAmericaSlimAgain Apr. 27 at 5:52 AM
$ALT interesting take https://www.linkedin.com/pulse/glp-1-market-has-split-most-people-havent-noticed-paul-healy--brrjf?utm_source=share&utm_medium=member_ios&utm_campaign=share_via
0 · Reply
BuddyBoy6975
BuddyBoy6975 Apr. 27 at 5:25 AM
$ALT Not an event where we’re gonna potentially hear what we wanna hear…. The news we want, Ph3 start, DOESN’T happen there…
0 · Reply
Chalutz
Chalutz Apr. 27 at 5:24 AM
$ALT why is someone always right not long retired with more interesting things to do that post here………? Weak dude……
0 · Reply
BuddyBoy6975
BuddyBoy6975 Apr. 27 at 5:08 AM
$ALT ALL I wanna hear is a Ph3 start date. ..! THAT’s when things START Plus Euro news. BIGLY …!!
0 · Reply
BuddyBoy6975
BuddyBoy6975 Apr. 27 at 5:03 AM
$ALT X-TREMELY
0 · Reply
StockDark
StockDark Apr. 27 at 4:02 AM
$ALT As long as the stockwit sentiment is bullish this won’t move an inch. It has to turn to bearish for the stock to move.
1 · Reply
2MargaritaLunch
2MargaritaLunch Apr. 27 at 3:08 AM
0 · Reply